|
REVENUE:
|
|
|
|
|
|
|
|
OPERATING INCOME
|
|
$45.3m
|
$41.5m
|
$54.6m
|
$58.6m
|
$56.5m
|
|
Depreciation
|
|
$17.8m
|
$16.5m
|
$15.3m
|
$14.4m
|
$14.3m
|
|
Amortization
|
|
$762k
|
$685k
|
$490k
|
$504k
|
$359k
|
|
Income before income taxes
|
|
$36.1m
|
$30.0m
|
$41.2m
|
$46.2m
|
$45.9m
|
|
Net income
|
|
$20.2m
|
$19.7m
|
$37.0m
|
$32.2m
|
$30.4m
|
|
Net income attributable to non-controlling interest
|
|
$492k
|
$205k
|
$350k
|
$753k
|
$722k
|
|
Net income attributable to Core Laboratories Inc.
|
|
$19.7m
|
$19.5m
|
$36.7m
|
$31.4m
|
$29.7m
|
|
Basic earnings per share
|
|
$0.44
|
$0.42
|
$0.79
|
$0.69
|
$0.65
|
|
Basic earnings per share attributable to Core Laboratories Inc.
|
|
$0
|
$0
|
$1
|
$1
|
$1
|
|
Diluted earnings per share
|
|
$0.43
|
$0.42
|
$0.78
|
$0.67
|
$0.65
|
|
Diluted earnings per share attributable to Core Laboratories Inc.
|
|
$0
|
$0
|
$1
|
$1
|
$1
|
|
Basic
|
|
$0.44
|
$0.42
|
$0.79
|
$0.69
|
$0.65
|
|
Diluted
|
|
$0.43
|
$0.42
|
$0.78
|
$0.67
|
$0.65
|
|
Cost of services and product sales exclusive of depreciation expense shown below
|
|
$367.9m
|
$393.7m
|
$400.0m
|
$420.5m
|
$417.6m
|
|
General and administrative expense, exclusive of depreciation expense shown below
|
|
$44.2m
|
$38.1m
|
$40.3m
|
$39.8m
|
$45.4m
|
|
Other (income) expense, net
|
|
($5.6m)
|
($722k)
|
($850k)
|
($10.0m)
|
($7.6m)
|
|
Interest expense
|
|
$9.2m
|
$11.6m
|
$13.4m
|
$12.4m
|
$10.6m
|
|
Income tax expense
|
|
$15.9m
|
$10.3m
|
($4.2m)
|
$14.0m
|
$15.5m
|